humans |
97 |
influenza |
78 |
animals |
65 |
adult |
56 |
female |
55 |
adolescent |
54 |
male |
53 |
hong kong - epidemiology |
50 |
middle aged |
47 |
sars-cov-2 |
45 |
coronavirus |
44 |
covid-19 |
44 |
child |
42 |
hong kong |
42 |
molecular sequence data |
40 |
child, preschool |
39 |
aged |
38 |
phylogeny |
36 |
influenza virus |
35 |
reverse transcriptase polymerase chain reaction |
33 |
transmission |
32 |
antibodies, viral - blood |
31 |
vaccine |
31 |
infant |
30 |
sars |
29 |
disease outbreaks - statistics & numerical data |
28 |
china - epidemiology |
27 |
disease outbreaks |
27 |
seasons |
27 |
time factors |
27 |
influenza a virus, h1n1 subtype - immunology |
25 |
china |
24 |
immunity |
24 |
population surveillance |
24 |
risk factors |
24 |
genome, viral |
23 |
respiratory system - virology |
23 |
feces - virology |
22 |
genetic predisposition to disease |
22 |
influenza, human - epidemiology - virology |
22 |
pandemics |
22 |
poultry - virology |
22 |
public health |
22 |
sequence analysis, dna |
22 |
swine |
22 |
base sequence |
21 |
cells, cultured |
21 |
children |
21 |
genotype |
21 |
h7n9 |
21 |
human |
21 |
prevalence |
21 |
rna, viral - genetics |
21 |
virus replication |
21 |
avian influenza |
20 |
evolution, molecular |
20 |
hospitalization |
20 |
influenza a virus, h1n1 subtype - physiology |
20 |
neutralization tests |
20 |
young adult |
20 |
amino acid sequence |
19 |
antigens, viral - analysis |
19 |
avian |
19 |
h5n1 |
19 |
influenza, human - virology |
19 |
pandemic |
19 |
prospective studies |
19 |
sars coronavirus |
19 |
severe acute respiratory syndrome |
19 |
vaccination |
19 |
antigens, cd - genetics |
18 |
birds - virology |
18 |
epidemiology |
18 |
immunity, innate |
18 |
influenza a virus, h5n1 subtype - immunology |
18 |
polymerase chain reaction |
18 |
reproducibility of results |
18 |
sars virus - immunology |
18 |
seroepidemiologic studies |
18 |
surveillance |
18 |
birds |
17 |
genetic variation |
17 |
molecular epidemiology |
17 |
serology |
17 |
swine - virology |
17 |
virus evolution |
17 |
antiviral agents - pharmacology |
16 |
antiviral agents - therapeutic use |
16 |
cell adhesion molecules - genetics |
16 |
cell line |
16 |
cercopithecus aethiops |
16 |
evolution |
16 |
hemagglutinin glycoproteins, influenza virus - genetics |
16 |
influenza a |
16 |
influenza, human - epidemiology - immunology - virology |
16 |
influenza, human - mortality |
16 |
mers-cov |
16 |
polymorphism, genetic |
16 |
tandem repeat sequences |
16 |
asia - epidemiology |
15 |
cell adhesion molecules - genetics - metabolism |
15 |
coronavac |
15 |
homozygote |
15 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
15 |
influenza in birds - epidemiology - virology |
15 |
influenza, human - epidemiology |
15 |
l-lactate dehydrogenase - blood |
15 |
lectins, c-type - genetics - metabolism |
15 |
polymorphism, single nucleotide - genetics |
15 |
receptors, cell surface - genetics - metabolism |
15 |
risk assessment |
15 |
viral proteins - genetics |
15 |
virulence |
15 |
animals, wild - virology |
14 |
antibodies |
14 |
cytokines - metabolism |
14 |
h1n1 |
14 |
hemagglutination inhibition tests |
14 |
influenza a virus, h1n1 subtype - immunology - pathogenicity |
14 |
influenza, human - immunology - virology |
14 |
mice |
14 |
neuraminidase - genetics |
14 |
pathogenicity |
14 |
polymerase chain reaction - methods |
14 |
sensitivity and specificity |
14 |
severity of illness index |
14 |
zoonosis |
14 |
conjunctiva - virology |
13 |
cross protection |
13 |
ducks - virology |
13 |
enzyme-linked immunosorbent assay |
13 |
influenza a virus, h5n1 subtype |
13 |
influenza, human - epidemiology - transmission - virology |
13 |
models, biological |
13 |
morbidity |
13 |
nasopharynx - virology |
13 |
organ culture techniques |
13 |
pathogenesis |
13 |
reverse transcriptase polymerase chain reaction - methods |
13 |
severe acute respiratory syndrome - virology |
13 |
universal vaccine |
13 |
viral load |
13 |
viral tropism |
13 |
virus shedding |
13 |
africa |
12 |
astroviridae infections - epidemiology - veterinary - virology |
12 |
bronchi - cytology |
12 |
case-control studies |
12 |
cohort studies |
12 |
coronavirus - classification - genetics - isolation & purification |
12 |
cross reactions |
12 |
cytokine |
12 |
cytokines - genetics - metabolism |
12 |
ferrets - virology |
12 |
immunoglobulin g - blood |
12 |
influenza a virus - isolation & purification |
12 |
influenza a virus, h1n1 subtype - metabolism |
12 |
influenza a virus, h5n1 subtype - genetics - immunology |
12 |
influenza a virus, h5n1 subtype - pathogenicity |
12 |
influenza in birds - epidemiology - transmission - virology |
12 |
influenza, human - diagnosis - virology |
12 |
lopinavir |
12 |
nf-kappa b - metabolism |
12 |
nose - virology |
12 |
pharynx - virology |
12 |
proteasome endopeptidase complex - metabolism |
12 |
protection |
12 |
receptors, cell surface - metabolism |
12 |
sars virus - genetics - isolation & purification |
12 |
serotyping |
12 |
severe acute respiratory syndrome - blood - genetics |
12 |
severe acute respiratory syndrome - diagnosis - virology |
12 |
signal transduction |
12 |
species specificity |
12 |
survival rate |
12 |
t cells |
12 |
up-regulation |
12 |
acute respiratory illness |
11 |
aged, 80 and over |
11 |
apoptosis |
11 |
cho cells - virology |
11 |
comorbidity |
11 |
coronavirus disease 2019 |
11 |
coronaviruses |
11 |
cricetinae |
11 |
cricetulus |
11 |
cytokines - immunology |
11 |
disease outbreaks - prevention & control |
11 |
dogs |
11 |
influenza a virus, h5n1 subtype - metabolism |
11 |
intestine, small - physiology |
11 |
intradermal |
11 |
lung - physiology - virology |
11 |
macrophages |
11 |
omicron |
11 |
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
11 |
polymorphism, single nucleotide |
11 |
rna, viral - metabolism |
11 |
sars virus - genetics |
11 |
sars virus - isolation & purification |
11 |
sars virus - metabolism - pathogenicity |
11 |
sars virus - physiology |
11 |
sars-cov |
11 |
sequence homology, amino acid |
11 |
severe acute respiratory syndrome - epidemiology - genetics |
11 |
species index: animalia |
11 |
vero cells - virology |
11 |
virus cultivation |
11 |
acute lung injury |
10 |
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
age distribution |
10 |
bayes theorem |
10 |
biodiversity |
10 |
chemicals and cas registry numbers |
10 |
confidence intervals |
10 |
conjunctiva |
10 |
cross-sectional studies |
10 |
cyclooxygenase 2 - biosynthesis - genetics |
10 |
cyclooxygenase 2 inhibitors |
10 |
dead-box rna helicases - genetics - immunology - metabolism |
10 |
disease burden |
10 |
dna probes - genetics |
10 |
epithelial cells - immunology - metabolism |
10 |
genes, viral |
10 |
hospitalization - statistics & numerical data |
10 |
hospitalization - statistics and numerical data |
10 |
hpai |
10 |
influenza a virus - physiology |
10 |
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
10 |
influenza a virus, h1n1 subtype - pathogenicity |
10 |
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h5n1 subtype - classification - genetics |
10 |
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
influenza in birds - enzymology - immunology - virology |
10 |
influenza, human - enzymology - virology |
10 |
influenza, human - immunology - metabolism - virology |
10 |
influenza, human - metabolism - transmission |
10 |
influenza, human - transmission - virology |
10 |
interferon regulatory factor-3 - metabolism |
10 |
ip-10 |
10 |
janus kinases - immunology |
10 |
macrophages - immunology - metabolism |
10 |
mers |
10 |
mesenchymal stromal cells |
10 |
neutralization |
10 |
p38 mitogen-activated protein kinases - metabolism |
10 |
pandemic h1n1 |
10 |
pandemic risk assessment |
10 |
paracrine communication - immunology |
10 |
patient admission - statistics and numerical data |
10 |
phenotype |
10 |
poisson distribution |
10 |
poultry |
10 |
probability |
10 |
pulmonary alveoli - immunology - metabolism |
10 |
reassortant viruses - isolation & purification |
10 |
receptor, interferon alpha-beta - immunology |
10 |
respiratory mucosa - virology |
10 |
rna, small interfering - genetics |
10 |
rna, viral - genetics - isolation & purification |
10 |
sars virus - genetics - metabolism |
10 |
severe acute respiratory syndrome - diagnosis |
10 |
singapore - epidemiology |
10 |
toll-like receptor 3 - metabolism |
10 |
transfection |
10 |
tropism |
10 |
vaccine effectiveness |
10 |
vietnam - epidemiology |
10 |
viral proteins - genetics - metabolism |
10 |
virus attachment |
10 |
2019 novel coronavirus disease |
9 |
abattoirs |
9 |
airborne |
9 |
alveolar fluid clearance |
9 |
chiroptera - classification - virology |
9 |
chiroptera - virology |
9 |
cohort |
9 |
contamination |
9 |
coronavirus - classification - genetics |
9 |
diagnosis, differential |
9 |
disease outbreaks - history |
9 |
disease reservoirs |
9 |
family health |
9 |
ferrets |
9 |
genetics |
9 |
history, 20th century |
9 |
history, 21st century |
9 |
human influenza |
9 |
infection |
9 |
influenza a virus |
9 |
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification |
9 |
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
influenza a virus, h1n1 subtype - genetics - pathogenicity |
9 |
influenza a virus, h3n2 subtype - classification - genetics - isolation & purification |
9 |
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
9 |
influenza a virus, h5n1 subtype - physiology |
9 |
influenza in birds - virology |
9 |
influenza vaccine |
9 |
influenza, human - epidemiology - prevention & control - transmission - virology |
9 |
influenza-virus |
9 |
killer cells, natural - immunology - virology |
9 |
kinetics |
9 |
mamastrovirus - classification - genetics - isolation & purification |
9 |
markov chains |
9 |
microbial sensitivity tests |
9 |
models, genetic |
9 |
molecular sequence numbers |
9 |
monte carlo method |
9 |
nucleocapsid proteins - genetics - immunology |
9 |
oseltamivir |
9 |
pneumonia, viral - virology |
9 |
reassortant viruses - classification - genetics - isolation and purification |
9 |
sars virus - pathogenicity |
9 |
seroepidemiology |
9 |
severe acute respiratory syndrome - blood - epidemiology |
9 |
swine - blood - virology |
9 |
swine diseases - blood - epidemiology - transmission - virology |
9 |
t-lymphocytes, cytotoxic - immunology |
9 |
treatment outcome |
9 |
viral envelope proteins - genetics - immunology |
9 |
viral shedding |
9 |
virus internalization |
9 |
2009 pandemic h1n1 influenza virus |
8 |
adenovirus |
8 |
age factors |
8 |
alveolar epithelial cells |
8 |
amino acid substitution |
8 |
antibody |
8 |
antibody titer |
8 |
antibody-dependent cellular cytotoxicity |
8 |
asia, southeastern |
8 |
autopsy |
8 |
baseline immunity |
8 |
betacoronavirus |
8 |
bioaerosol |
8 |
bronchi - immunology - pathology |
8 |
canada - epidemiology |
8 |
cell adhesion molecules - genetics - physiology |
8 |
cell polarity |
8 |
characterization |
8 |
chemokines |
8 |
cluster analysis |
8 |
coronavirus disease |
8 |
coronavirus infection |
8 |
coronavirus infections |
8 |
coronavirus infections - veterinary - virology |
8 |
cytopathogenic effect, viral |
8 |
databases, nucleic acid - statistics & numerical data |
8 |
disease progression |
8 |
disease surveillance |
8 |
dna, viral - genetics |
8 |
enzyme-linked immunosorbent assay - methods |
8 |
family characteristics |
8 |
genes, viral - genetics |
8 |
ha stem antibodies |
8 |
hemagglutinin |
8 |
human exhaled breath |
8 |
immunohistochemistry |
8 |
incidence rates |
8 |
influenza a virus - classification - genetics - pathogenicity |
8 |
influenza a virus - genetics |
8 |
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
influenza a virus, h9n2 subtype |
8 |
influenza virus infection |
8 |
influenza, human - immunology |
8 |
innate host responses |
8 |
lectins, c-type - genetics |
8 |
macrophages - immunology |
8 |
mask |
8 |
medical sciences |
8 |
mice, inbred balb c |
8 |
middle east respiratory syndrome coronavirus |
8 |
mortality |
8 |
nucleic acid amplification techniques - methods |
8 |
orthomyxoviridae infections - epidemiology - veterinary - virology |
8 |
orthomyxoviridae infections - transmission |
8 |
oseltamivir - therapeutic use |
8 |
pandemics - statistics and numerical data |
8 |
positive selection |
8 |
poultry diseases - epidemiology - virology |
8 |
pulmonary alveoli - immunology |
8 |
reagent kits, diagnostic |
8 |
reassortant viruses - classification - genetics - isolation & purification |
8 |
receptors, cell surface - genetics |
8 |
respiratory mucosa - immunology - pathology |
8 |
rna, viral - analysis - genetics |
8 |
sars virus - genetics - immunology |
8 |
sars virus - immunology - isolation & purification |
8 |
sars virus - isolation and purification - pathogenicity |
8 |
sequence homology |
8 |
serial |
8 |
severe acute respiratory syndrome - epidemiology - transmission - virology |
8 |
severe acute respiratory syndrome - physiopathology - virology |
8 |
severity |
8 |
statistics |
8 |
stool |
8 |
swine diseases - epidemiology - transmission - virology |
8 |
swine influenza virus |
8 |
tumor necrosis factor-alpha - biosynthesis - genetics |
8 |
universal immune correlate |
8 |
urine |
8 |
urine - virology |
8 |
viral load - physiology |
8 |
viral plaque assay |
8 |
viral proteins - chemistry - genetics |
8 |
viruses |
8 |
2009 h1n1 influenza |
7 |
25-hydroxyvitamin d |
7 |
5′-race assay |
7 |
airborne particles |
7 |
alleles |
7 |
amplicon |
7 |
animal tissue |
7 |
antibodies, monoclonal - immunology |
7 |
antibody-dependent enhancement |
7 |
antigenic variation |
7 |
antiviral compounds |
7 |
asian continental ancestry group - genetics |
7 |
astroviridae - classification - genetics - isolation and purification |
7 |
asymptomatic |
7 |
bird diseases - epidemiology - virology |
7 |
blood |
7 |
blotting, western |
7 |
bone marrow transplantation |
7 |
bronchial tissue |
7 |
cd209 |
7 |
cell-mediated immunity |
7 |
chicken |
7 |
chlorogenic acid - chemistry - pharmacology |
7 |
consensus sequence |
7 |
coronavirus - classification - enzymology - genetics - isolation & purification |
7 |
coronavirus - immunology |
7 |
cytokines |
7 |
cytokines - biosynthesis - genetics |
7 |
cytotoxicity |
7 |
dc-sign |
7 |
death |
7 |
dna - metabolism |
7 |
dna primers |
7 |
dna-directed dna polymerase - genetics - metabolism |
7 |
drug synergism |
7 |
dynamics |
7 |
early warnings |
7 |
electrophoretic mobility shift assay |
7 |
epidemics |
7 |
etiology |
7 |
exercise - physiology |
7 |
fatal outcome |
7 |
felidae - virology |
7 |
flavonoids - chemistry - pharmacology |
7 |
gene expression regulation, viral - physiology |
7 |
gene frequency - genetics |
7 |
genomic sequence |
7 |
glycyrrhizic acid - chemistry - pharmacology |
7 |
hela cells |
7 |
hemagglutinin glycoproteins, influenza virus - genetics - immunology |
7 |
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
hemagglutinins - genetics - metabolism |
7 |
heterozygote |
7 |
highly pathogenic avian influenza |
7 |
immunoassay - methods |
7 |
immunology |
7 |
infectiousness |
7 |
influenza a virus - classification - genetics |
7 |
influenza a virus - classification - genetics - isolation & purification |
7 |
influenza a virus - genetics - isolation & purification |
7 |
influenza a virus - immunology |
7 |
influenza a virus - pathogenicity |
7 |
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification - pathogenicity |
7 |
influenza a virus, h5n1 subtype - drug effects |
7 |
influenza a virus, h5n1 subtype - genetics |
7 |
influenza a virus, h5n1 subtype - genetics - isolation & purification |
7 |
influenza b virus |
7 |
influenza in birds - transmission - virology |
7 |
influenza vaccines |
7 |
influenza vaccines - administration & dosage |
7 |
influenza vaccines - immunology |
7 |
influenza, human - complications - mortality - therapy |
7 |
influenza, human - epidemiology - history |
7 |
influenza, human - pathology - virology |
7 |
interferon-alpha - pharmacology |
7 |
interferon-beta - pharmacology |
7 |
lactate dehydrogenase |
7 |
life style |
7 |
lung - pathology - virology |
7 |
lung - radiography |
7 |
membrane glycoproteins - genetics - immunology |
7 |
molecular clock |
7 |
mustelidae - virology |
7 |
myelosuppression |
7 |
nasal tissue |
7 |
nasopharynx/virology |
7 |
neuraminidase - metabolism |
7 |
neutralizing antibody |
7 |
nuclear proteins - metabolism |
7 |
nucleocapsid - analysis |
7 |
nucleocapsid proteins - genetics |
7 |
omicron ba.2 |
7 |
open reading frames - genetics |
7 |
orthomyxoviridae - isolation & purification |
7 |
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
promoter regions, genetic - genetics |
7 |
protein binding - genetics |
7 |
pyrimidinones - pharmacology |
7 |
quail - virology |
7 |
rapid diagnosis |
7 |
reassortant |
7 |
regression analysis |
7 |
respiratory infections |
7 |
respiratory syncytial viruses - isolation & purification |
7 |
retrospective studies |
7 |
ribavirin - pharmacology |
7 |
rimantadine - pharmacology |
7 |
rna helicases - genetics |
7 |
rna replicase - genetics |
7 |
rna, viral - analysis |
7 |
rodent diseases - virology |
7 |
sars cov |
7 |
sars virus - chemistry |
7 |
sars virus - drug effects |
7 |
sars virus - isolation and purification |
7 |
sars-coronavirus seroprevalence |
7 |
saudi arabia |
7 |
severe acute respiratory syndrome - blood - physiopathology - urine - virology |
7 |
severe acute respiratory syndrome - diagnosis - epidemiology - virology |
7 |
severe acute respiratory syndrome - epidemiology - history - virology |
7 |
sewage surveillance |
7 |
sewage system characteristics |
7 |
smoking |
7 |
snp |
7 |
sp1 transcription factor - genetics |
7 |
specimen handling - methods |
7 |
subgenomic transcripts |
7 |
swine diseases - virology |
7 |
transcription factor ap-2 - genetics |
7 |
tropical climate |
7 |
tumor necrosis factor-alpha - metabolism |
7 |
vaccination - veterinary |
7 |
viral genes |
7 |
virology - methods |
7 |
administration, oral |
6 |
aerosols |
6 |
age |
6 |
air pollution |
6 |
air pollution - adverse effects |
6 |
air travel-related outbreak |
6 |
airway epithelial cells |
6 |
amantadine-pharmacology |
6 |
amoxicillin-potassium clavulanate combination - administration & dosage |
6 |
analysis of variance |
6 |
animal cell |
6 |
animal experiment |
6 |
animal model |
6 |
antibiotic prophylaxis |
6 |
antibodies, monoclonal - diagnostic use |
6 |
antibodies, neutralizing - blood |
6 |
antibodies, viral - metabolism |
6 |
antibody specificity |
6 |
antigens, viral - genetics |
6 |
antigens, viral - immunology |
6 |
antiviral |
6 |
australasia - epidemiology |
6 |
biodiversity conservation |
6 |
biopsy |
6 |
bnt162b2 |
6 |
bronchi - pathology |
6 |
camel |
6 |
carnivora - virology |
6 |
cats |
6 |
cattle |
6 |
caveolins |
6 |
cell nucleus - ultrastructure |
6 |
chickens - immunology |
6 |
cigarette smoking |
6 |
clade 2.3.4.4.b |
6 |
clinical phenotype |
6 |
co-infection |
6 |
communicable diseases - genetics - physiopathology |
6 |
conservation |
6 |
conservation of natural resources |
6 |
controlled study |
6 |
coronaviridae - classification - genetics - isolation & purification - physiology |
6 |
coronaviridae infections - transmission - veterinary - virology |
6 |
coronavirus - classification - genetics - immunology - isolation & purification |
6 |
coronavirus - classification - isolation & purification - ultrastructure |
6 |
coronavirus 229e, human - immunology |
6 |
coronavirus infections - diagnosis - transmission - virology |
6 |
coronavirus oc43, human - immunology |
6 |
cost of illness |
6 |
cox model |
6 |
cross infection - complications |
6 |
cross-reactive antibody |
6 |
cross-reactive antibody response |
6 |
demography |
6 |
diarrhea - microbiology |
6 |
disease reservoirs - veterinary - virology |
6 |
disease reservoirs - virology |
6 |
disease transmission |
6 |
disease transmission control |
6 |
disease transmission, infectious - statistics & numerical data |
6 |
dna helicases - classification - genetics - metabolism |
6 |
dna, viral - classification - genetics |
6 |
dna, viral - genetics - metabolism |
6 |
drug-resistance,-viral-genetics |
6 |
ducks - genetics - virology |
6 |
ducks - immunology |
6 |
early diagnosis |
6 |
ecology |
6 |
ecosystem |
6 |
endemic diseases - statistics & numerical data |
6 |
environment |
6 |
enzyme linked immunosorbent assay |
6 |
europe - epidemiology |
6 |
ex vivo |
6 |
explants |
6 |
far east - epidemiology |
6 |
fever - diagnosis |
6 |
flow cytometry |
6 |
follow-up studies |
6 |
fractional factorial design |
6 |
ganciclovir |
6 |
gastrointestinal diseases - microbiology |
6 |
geese - immunology |
6 |
gene expression regulation |
6 |
gene frequency |
6 |
genomic diversity |
6 |
genomic epidemiology |
6 |
giant cells - ultrastructure |
6 |
gram-positive bacteria - isolation & purification |
6 |
gram-positive bacterial infections - microbiology |
6 |
guidelines as topic |
6 |
hemagglutinins, viral - immunology |
6 |
hiv protease inhibitors - therapeutic use |
6 |
immune response |
6 |
immunization (vaccination) |
6 |
immunocompromised host - immunology |
6 |
inborn errors of immunity |
6 |
infant, newborn |
6 |
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification - pathogenicity |
6 |
influenza a virus, h1n1 subtype - isolation and purification |
6 |
influenza a virus, h1n2 subtype - classification - genetics - isolation & purification |
6 |
influenza a virus, h3n2 subtype - genetics - pathogenicity |
6 |
influenza a virus, h3n2 subtype - genetics - physiology |
6 |
influenza a virus, h5n1 subtype - classification - immunology |
6 |
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification - pathogenicity |
6 |
influenza a virus, h5n1 subtype - immunology - isolation & purification |
6 |
influenza a virus, h9n2 subtype - chemistry - classification |
6 |
influenza a virus, h9n2 subtype - genetics - immunology |
6 |
influenza a virus, h9n2 subtype - isolation & purification |
6 |
influenza a virus, h9n2 subtype - physiology |
6 |
influenza a(h1n1)pdm09 |
6 |
influenza a(h5n1) |
6 |
influenza b |
6 |
influenza in birds - diagnosis - genetics - virology |
6 |
influenza in birds - immunology - prevention & control |
6 |
influenza in birds - immunology - virology |
6 |
influenza polymerase |
6 |
influenza vaccines - administration & dosage - immunology |
6 |
influenza, human - blood - epidemiology - virology |
6 |
influenza, human - complications - diagnosis - epidemiology |
6 |
influenza, human - complications - epidemiology |
6 |
influenza, human - diagnosis - genetics - virology |
6 |
influenza, human - epidemiology - prevention & control - virology |
6 |
influenza, human - transmission |
6 |
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
influenza-a-virus,-h5n1-subtype-genetics |
6 |
influenzavirus a - genetics - immunology - pathogenicity |
6 |
infusions, intravenous |
6 |
isolation |
6 |
killer cells, natural - virology |
6 |
length of stay |
6 |
macrophages - immunology - virology |
6 |
membrane glycoproteins - chemistry - genetics |
6 |
metaplasia |
6 |
metapneumovirus - isolation & purification |
6 |
methods |
6 |
microscopy, electron |
6 |
molecular diagnostic techniques - methods |
6 |
mutation |
6 |
mutation - genetics |
6 |
nasal cavity - virology |
6 |
neuraminidase inhibition antibody |
6 |
new york - epidemiology |
6 |
nsp6 |
6 |
nucleocapsid proteins - analysis |
6 |
nucleocapsid proteins - immunology |
6 |
nucleocapsid proteins - isolation & purification |
6 |
nucleoside-triphosphatase - classification - genetics - metabolism |
6 |
odds ratio |
6 |
ofloxacin |
6 |
opportunistic infections - diagnosis - transmission - virology |
6 |
organ size |
6 |
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
orthomyxoviridae - immunology - pathogenicity |
6 |
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
orthomyxoviridae infections - transmission - virology |
6 |
owston's civet |
6 |
parainfluenza virus 3, human - isolation & purification |
6 |
paramyxoviridae infections - diagnosis - epidemiology - virology |
6 |
peg precipitation |
6 |
phylogeography |
6 |
placebos - administration & dosage |
6 |
pneumonia - diagnosis - veterinary - virology |
6 |
pneumonia - etiology |
6 |
population dynamics |
6 |
poultry diseases - prevention & control |
6 |
pregnancy |
6 |
pregnancy complications, infectious - diagnosis - therapy |
6 |
prognosis |
6 |
protein conformation |
6 |
pulmonary alveoli - immunology - virology |
6 |
pulse therapy, drug |
6 |
pyrimidinones - therapeutic use |
6 |
quantitative rt-pcr |
6 |
quarantine - veterinary |
6 |
real time rt-pcr |
6 |
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
receptors, antigen, t-cell, gamma-delta - immunology |
6 |
rectum - virology |
6 |
reference values |
6 |
referral and consultation |
6 |
regional index: china |
6 |
residence characteristics |
6 |
residence characteristics - statistics and numerical data |
6 |
respiratory syncytial virus infections - diagnosis - epidemiology - virology |
6 |
respiratory tract infections |
6 |
respiratory tract infections - diagnosis - epidemiology - virology |
6 |
reverse transcriptase polymerase chain reaction - methods - standards |
6 |
rimantadine-pharmacology |
6 |
ritonavir - therapeutic use |
6 |
rna helicases - classification - genetics - metabolism |
6 |
rna interference |
6 |
rna, messenger - analysis |
6 |
rna, viral |
6 |
rna, viral - analysis - isolation & purification |
6 |
rt-qpcr |
6 |
sars coronavirus 2 |
6 |
sars virus |
6 |
sars virus - classification - genetics - immunology - isolation & purification |
6 |
sars virus - enzymology - genetics |
6 |
sars virus - genetics - immunology - isolation & purification |
6 |
sars virus - metabolism |
6 |
school |
6 |
selection, genetic |
6 |
sensitivity |
6 |
sequence deletion |
6 |
sequence homology, nucleic acid |
6 |
sequence variation |
6 |
severe acute respiratory syndrome - blood - immunology |
6 |
severe acute respiratory syndrome - complications - immunology |
6 |
severe acute respiratory syndrome - complications - pathology - virology |
6 |
severe acute respiratory syndrome - diagnosis - drug therapy - epidemiology - virology |
6 |
severe acute respiratory syndrome - diagnosis - immunology |
6 |
severe acute respiratory syndrome - diagnosis - immunology - virology |
6 |
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
severe acute respiratory syndrome - diagnosis - urine |
6 |
severe acute respiratory syndrome - drug therapy - virology |
6 |
severe acute respiratory syndrome - epidemiology |
6 |
severe acute respiratory syndrome - epidemiology - microbiology |
6 |
severe acute respiratory syndrome - genetics - physiopathology |
6 |
severe acute respiratory syndrome - immunology - virology |
6 |
severe acute respiratory syndrome - mortality - physiopathology - virology |
6 |
sex distribution |
6 |
solar radiation |
6 |
source-sink |
6 |
specificity |
6 |
specimen handling |
6 |
substrate specificity |
6 |
surface |
6 |
t cell epitope |
6 |
t-lymphocytes - immunology - metabolism |
6 |
tumor necrosis factor-alpha - genetics - metabolism |
6 |
vaccination - methods |
6 |
vaccines, inactivated - administration & dosage - immunology |
6 |
variant |
6 |
vero cells |
6 |
victoria lineage |
6 |
viral envelope proteins - chemistry - genetics |
6 |
viral load - statistics & numerical data |
6 |
virion - immunology |
6 |
virus |
6 |
virus outbreak |
6 |
vitamin d |
6 |
viverrid |
6 |
viverridae - anatomy & histology - physiology - virology |
6 |
viverridae - virology |
6 |
wastewater genome sequencing |
6 |
wastewater surveillance |
6 |
wastewater-based epidemiology |
6 |
whole genome sequencing |
6 |
wild species infections |
6 |
yamagata lineage |
6 |
zoonoses |
6 |
zoonoses - epidemiology |
6 |
actins - genetics |
5 |
acyclovir - therapeutic use |
5 |
adaptation |
5 |
adaptation, biological |
5 |
air pollutants - toxicity |
5 |
air-sampler |
5 |
amino acid motifs |
5 |
animal migration |
5 |
antibodies, neutralizing - blood - immunology |
5 |
antibodies, viral - blood - immunology |
5 |
antibodies, viral - immunology |
5 |
antibody response |
5 |
antigen detection |
5 |
avian influenza virus |
5 |
avian influenza virus (aiv) |
5 |
betacoronaviruses |
5 |
bioinformatics |
5 |
birds - physiology - virology |
5 |
bone marrow transplantation - adverse effects |
5 |
bone marrow transplantation - immunology |
5 |
burden |
5 |
c-type lectins |
5 |
calibration |
5 |
cardiorespiratory disease |
5 |
cardiovascular diseases - mortality |
5 |
case-only approach |
5 |
cause of death |
5 |
chemokine ccl2 - biosynthesis |
5 |
chemokine cxcl10 - biosynthesis |
5 |
chicken meat |
5 |
chickens |
5 |
children. |
5 |
clade 2.3.4.4 |
5 |
clec5a |
5 |
cmv |
5 |
cofactors |
5 |
cohort study |
5 |
communicable diseases - classification |
5 |
communicable diseases, emerging |
5 |
community-acquired infections |
5 |
confounding |
5 |
consensus primers |
5 |
conserved sequence |
5 |
contact tracing |
5 |
coronavirus - classification - isolation and purification |
5 |
coronavirus - genetics - isolation & purification |
5 |
cyclosporine |
5 |
cytomegalovirus - drug effects - genetics - isolation & purification |
5 |
cytomegalovirus - genetics - immunology - pathogenicity |
5 |
cytomegalovirus infections - immunology - virology |
5 |
cytotoxicity, immunologic |
5 |
deprivation |
5 |
diagnostics |
5 |
diarrhea |
5 |
diphosphonates - pharmacology |
5 |
direction infection |
5 |
dna, complementary - analysis |
5 |
dna, protozoan - blood - genetics |
5 |
dna, ribosomal - analysis |
5 |
dna, viral - analysis - genetics |
5 |
dna, viral - blood |
5 |
dna, viral - blood - drug effects |
5 |
dna, viral - chemistry - genetics |
5 |
dromedary camels |
5 |
droplet |
5 |
drug resistance, viral |
5 |
effect modification |
5 |
effects modification |
5 |
elderly |
5 |
elisa |
5 |
emergency service, hospital |
5 |
emetine |
5 |
encephalities |
5 |
endothelial cells - immunology - virology |
5 |
epithelial cells - immunology - virology |
5 |
ex vivo explants |
5 |
feces analysis |
5 |
fomite |
5 |
gamma ifn |
5 |
genetic difference |
5 |
glycosylation |
5 |
graft vs host disease |
5 |
gtp-binding proteins - genetics - immunology |
5 |
gyrovirus |
5 |
h5n1 influenza virus |
5 |
h7n9 influenza virus |
5 |
handwashing |
5 |
haplorhini |
5 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics |
5 |
hemagglutinin glycoproteins, influenza virus - classification - genetics |
5 |
herpesviridae infections - blood - drug therapy - etiology |
5 |
herpesvirus 6, human - drug effects - genetics - isolation & purification |
5 |
herpesvirus 7, human - drug effects - genetics - isolation & purification |
5 |
hot temperature |
5 |
hpai h5nx |
5 |
human density |
5 |
illness |
5 |
immune memory |
5 |
immunization, passive |
5 |
immunoevasion |
5 |
immunogenicity |
5 |
indirubin |
5 |
influenza a virus - classification - enzymology - genetics |
5 |
influenza a virus - classification - genetics - isolation and purification - pathogenicity |
5 |
influenza a virus - genetics - metabolism - physiology |
5 |
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification |
5 |
influenza a virus, h2n2 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h3n2 subtype - classification - genetics - isolation and purification |
5 |
influenza a virus, h5n1 subtype - pathogenicity - physiology |
5 |
influenza a virus, h9n2 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
5 |
influenza a virus, h9n2 subtype - genetics - pathogenicity |
5 |
influenza activity |
5 |
influenza and respiratory viruses |
5 |
influenza b virus - isolation & purification |
5 |
influenza b virus - physiology |
5 |
influenza in birds - epidemiology - genetics |
5 |
influenza virus a h9n2 |
5 |
influenza, human - drug therapy - transmission - virology |
5 |
influenza, human - epidemiology - immunology |
5 |
influenza, human - epidemiology - physiopathology |
5 |
influenza, human - metabolism |
5 |
influenza, human - prevention and control - virology |
5 |
inhalation |
5 |
inhibition |
5 |
injections, intradermal |
5 |
inpatients |
5 |
interferon-alpha - immunology |
5 |
interferon-beta - immunology |
5 |
interferons - metabolism - pharmacology |
5 |
intradermal influenza vaccination |
5 |
leukocytes, mononuclear - virology |
5 |
lineage specific |
5 |
longitudinal studies |
5 |
lpai |
5 |
lung |
5 |
lung - cytology - drug effects - virology |
5 |
lung - drug effects - metabolism - virology |
5 |
lymphocytes - virology |
5 |
malaria, falciparum - blood - diagnosis |
5 |
masks |
5 |
maternal |
5 |
membrane glycoproteins - genetics |
5 |
membrane glycoproteins - metabolism |
5 |
middle east respiratory syndrome coronavirus (mers-cov) |
5 |
molecular diagnostic techniques - economics - methods |
5 |
mpox virus |
5 |
natural killer (nk) cell |
5 |
neuraminidase inhibitors |
5 |
neutralization tests - methods |
5 |
nitrogen dioxide - analysis - toxicity |
5 |
non-influenza respiratory virus |
5 |
non-influenza respiratory virus infection |
5 |
nonhuman |
5 |
norovirus |
5 |
nucleocapsid proteins - genetics - metabolism |
5 |
nucleoprotein |
5 |
obesity |
5 |
one health |
5 |
open reading frames |
5 |
opportunistic infections - immunology - virology |
5 |
orthomyxoviridae - isolation and purification |
5 |
orthomyxoviridae infections - diagnosis - virology |
5 |
orthomyxoviridae infections - drug therapy - immunology - pathology |
5 |
orthomyxoviridae infections - epidemiology - immunology |
5 |
outpatient |
5 |
ozone - analysis - toxicity |
5 |
ozone - toxicity |
5 |
particulate matter - analysis - toxicity |
5 |
pcr |
5 |
peptidyl-dipeptidase a - metabolism |
5 |
plasmodium falciparum - genetics - isolation & purification |
5 |
pneumocytes |
5 |
polymerase chain reaction - economics - methods - standards |
5 |
polymerase genes |
5 |
promoter regions, genetic |
5 |
r292k na mutation |
5 |
randomized controlled trial |
5 |
real-time pcr |
5 |
reassortant viruses - classification - genetics - isolation and purification - pathogenicity |
5 |
receptors, igg - metabolism |
5 |
recombinant fusion proteins - pharmacology |
5 |
recombinant proteins - immunology |
5 |
reference standards |
5 |
remdesivir |
5 |
resistance |
5 |
respiration disorders - mortality |
5 |
respiratory |
5 |
reverse transcriptase polymerase chain reaction - economics - methods |
5 |
ritonavir |
5 |
rna replicase - chemistry - genetics |
5 |
rna replicase - genetics - metabolism |
5 |
rna, ribosomal, 18s - genetics |
5 |
rna, viral - analysis - genetics - isolation & purification |
5 |
rotavirus |
5 |
sars virus - genetics - growth & development - isolation & purification |
5 |
satellite tracking |
5 |
seasonal influenza |
5 |
seasonality |
5 |
selection |
5 |
self-examination - methods |
5 |
serial passage |
5 |
serologic tests - methods |
5 |
seroprevalence |
5 |
severe acute respiratory syndrome - blood - mortality - virology |
5 |
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
severe acute respiratory syndrome - epidemiology - immunology - transmission |
5 |
severe acute respiratory syndrome - genetics - immunology |
5 |
sex factors |
5 |
signal transduction - physiology |
5 |
social class |
5 |
spleen tyrosine kinase (syk) |
5 |
sulfur dioxide - analysis - toxicity |
5 |
swine diseases - epidemiology - virology |
5 |
symptom |
5 |
symptoms |
5 |
syrian hamsters |
5 |
t-lymphocyte subsets - drug effects - immunology |
5 |
temporal pattern |
5 |
temporary protection |
5 |
test-negative design |
5 |
time series analysis |
5 |
triavalent influenza vaccine |
5 |
type i interferon |
5 |
urban health |
5 |
vaccine efficacy |
5 |
vaccine match |
5 |
vaccines |
5 |
vietnam |
5 |
viral envelope proteins - genetics |
5 |
viral envelope proteins - genetics - metabolism |
5 |
viral matrix proteins - genetics |
5 |
viral matrix proteins - genetics - metabolism |
5 |
viral nonstructural proteins - genetics |
5 |
viral nonstructural proteins - genetics - metabolism - physiology |
5 |
virulence factors - genetics - metabolism |
5 |
virus assembly |
5 |
virus dna |
5 |
virus interference |
5 |
wild birds |
5 |
young infants |
5 |
2019 ncov whu01 |
4 |
accuracy |
4 |
acute disease |
4 |
adjuvants, immunologic - administration and dosage |
4 |
airborne transmission |
4 |
algorithm |
4 |
animals, domestic - virology |
4 |
animals, wild |
4 |
anti-neuraminidase antibody |
4 |
antibodies, bacterial - immunology |
4 |
antibody dependent enhancement |
4 |
antibody titerarticleblood donor |
4 |
antigen binding |
4 |
antigenic cartography |
4 |
antigens, cd27 - analysis |
4 |
antigens, cd45 - analysis |
4 |
antigens, viral - analysis - immunology |
4 |
antigens, viral - classification - genetics - immunology |
4 |
antimicrobial resistance |
4 |
antiviral agents - pharmacokinetics - pharmacology |
4 |
asia, southeastern - epidemiology |
4 |
asthma - complications |
4 |
asthma exacerbation |
4 |
asymptomatic cases |
4 |
bacterial pneumonia |
4 |
bangkok |
4 |
betacov/nepal/61/2020 |
4 |
bird diseases - epidemiology - transmission - virology |
4 |
bivalent rna vaccine |
4 |
bronchi - metabolism - virology |
4 |
cardiovascular diseases - chemically induced - mortality |
4 |
caveolin 1 - metabolism |
4 |
cell function |
4 |
cell isolation |
4 |
cell migration |
4 |
charadriiformes - physiology - virology |
4 |
chemistry |
4 |
chickens - virology |
4 |
child hospitalization |
4 |
children <5 years |
4 |
codon usage analysis |
4 |
cohort analysis |
4 |
coinfection - virology |
4 |
communicable diseases, emerging - epidemiology - virology |
4 |
coronavirus infections - diagnosis - mortality |
4 |
correlate of protection |
4 |
cross infection - transmission |
4 |
cross‐neutralization |
4 |
cytomegalovirus - genetics - isolation & purification |
4 |
daily life activity |
4 |
diagnostic tests |
4 |
disease association |
4 |
disease ecology |
4 |
dose-response relationship, drug |
4 |
dromedary |
4 |
dromedary camel |
4 |
droplet transmission |
4 |
drug therapy, combination |
4 |
ducks |
4 |
effective reproduction number |
4 |
effectiveness |
4 |
epidemiological monitoring - veterinary |
4 |
epithelium - virology |
4 |
equine coronavirus |
4 |
ethiopia |
4 |
ex vivo bronchi |
4 |
extracellular signal-regulated map kinases - metabolism |
4 |
eye tissue |
4 |
farnesyl transferase inhibitor |
4 |
fcγ receptor |
4 |
fludase |
4 |
foscarnet |
4 |
geese - physiology - virology |
4 |
gene pool |
4 |
genome, viral - genetics |
4 |
h2 |
4 |
h9n2 |
4 |
hae |
4 |
hajj |
4 |
healthcare workers |
4 |
hemagglutination inhibition |
4 |
hemagglutinins, viral - classification - genetics - immunology |
4 |
heterosubtypic immunity |
4 |
hku23 |
4 |
hospital units - organization & administration |
4 |
host response |
4 |
host-pathogen interactions - genetics - immunology |
4 |
human respiratory epithelial cell in vitro cultures |
4 |
human respiratory organ ex vivo cultures |
4 |
hygiene |
4 |
il-15 |
4 |
immune evasion |
4 |
immunity, duration |
4 |
immunoassay |
4 |
immunoenzyme techniques |
4 |
infection-naïve |
4 |
infectious disease surveillance |
4 |
infectious diseases |
4 |
inflammation - immunology - metabolism |
4 |
influenza a virus - classification - genetics - growth & development - isolation & |
4 |
influenza a virus - classification - isolation & purification - pathogenicity |
4 |
influenza a virus - genetics - immunology - isolation and purification |
4 |
influenza a virus - genetics - isolation and purification |
4 |
influenza a virus - immunology - isolation and purification |
4 |
influenza a virus - isolation and purification |
4 |
influenza a virus, h1n1 subtype - classification - genetics |
4 |
influenza a virus, h1n1 subtype - genetics |
4 |
influenza a virus, h1n1 subtype - genetics - immunology - isolation and purification |
4 |
influenza a virus, h1n1 subtype - immunology - isolation and purification |
4 |
influenza a virus, h1n1 subtype - immunology - metabolism |
4 |
influenza a virus, h1n1 subtype - pathogenicity - physiology |
4 |
influenza a virus, h1n2 subtype - pathogenicity |
4 |
influenza a virus, h3n2 subtype |
4 |
influenza a virus, h3n2 subtype - immunology - pathogenicity |
4 |
influenza a virus, h3n2 subtype - isolation and purification |
4 |
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification |
4 |
influenza a virus, h5n1 subtype - genetics - pathogenicity |
4 |
influenza a virus, h5n1 subtype - immunology - pathogenicity |
4 |
influenza a virus, h7n9 subtype - drug effects - genetics - isolation and purification |
4 |
influenza a virus, h9n2 subtype - immunology - metabolism |
4 |
influenza b virus - immunology - isolation and purification |
4 |
influenza b virus - isolation and purification |
4 |
influenza in birds - epidemiology - transmission |
4 |
influenza vaccines - genetics - immunology |
4 |
influenza virus vaccines |
4 |
influenza, human - complications - epidemiology - mortality |
4 |
influenza, human - diagnosis - mortality |
4 |
influenza, human - diagnosis - prevention & control - transmission |
4 |
influenza, human - drug therapy - virology |
4 |
influenza, human - epidemiology - immunology - pathology - physiopathology |
4 |
influenza, human - epidemiology - mortality |
4 |
influenza, human - epidemiology - pathology - virology |
4 |
influenza, human - epidemiology - prevention and control - transmission |
4 |
influenza, human - epidemiology - transmission - veterinary - virology |
4 |
influenza, human - prevention & control |
4 |
innate sensing receptors |
4 |
interferons - metabolism |
4 |
interim |
4 |
interleukin-12 - biosynthesis - metabolism |
4 |
interleukin-15 - administration and dosage - immunology |
4 |
introns |
4 |
kidney transplantation |
4 |
kuwait - epidemiology |
4 |
laos - epidemiology |
4 |
leukocytes - virology |
4 |
leukocytes, mononuclear - cytology |
4 |
live vector vaccines |
4 |
lower respiratory tract infection |
4 |
lysine - genetics |
4 |
macrophage |
4 |
macrophages - virology |
4 |
mannose-binding lectin - immunology - metabolism |
4 |
masks - statistics and numerical data |
4 |
middle east respiratory syndrome |
4 |
migratory ducks |
4 |
molecular diagnosis |
4 |
molecular typing |
4 |
monocytes - cytology |
4 |
mutation, missense |
4 |
neuroinflammation |
4 |
omicron subvariant |
4 |
orthomyxoviridae - drug effects |
4 |
orthomyxoviridae infections - immunology - metabolism - pathology - virology |
4 |
orthomyxoviridae infections - immunology - physiopathology |
4 |
orthomyxoviridae infections - immunology - prevention and control |
4 |
orthomyxoviridae infections - veterinary - virology |
4 |
orthomyxoviridae infections - virology |
4 |
p38 mitogen-activated protein kinases - antagonists & inhibitors - physiology |
4 |
pandemic a ⁄ h1n1 |
4 |
parvoviridae infections - transmission |
4 |
parvovirus b19, human |
4 |
pathology |
4 |
patient admission - statistics & numerical data |
4 |
patient compliance |
4 |
patient education as topic |
4 |
pb2 |
4 |
pb2 627 residue |
4 |
pb2-627 |
4 |
pediatrics |
4 |
picornaviridae infections - diagnosis - epidemiology - physiopathology - virology |
4 |
pneumonia |
4 |
point mutation |
4 |
point-of care |
4 |
pollution |
4 |
polymerase |
4 |
pseudotypes |
4 |
random mutagenesis |
4 |
real time-pcr |
4 |
reassortant viruses - classification - genetics |
4 |
reassortant viruses - genetics |
4 |
reassortant viruses - genetics - isolation and purification |
4 |
reassortant viruses - immunology - isolation and purification |
4 |
receptors, fc - metabolism |
4 |
recombinant fusion proteins - pharmacokinetics - pharmacology |
4 |
recombination, genetic |
4 |
repeated vaccination |
4 |
respiratory distress syndrome, adult - immunology |
4 |
respiratory mucosa - cytology - metabolism - virology |
4 |
respiratory syncytial virus infections - diagnosis - mortality |
4 |
respiratory syncytial virus infections - epidemiology |
4 |
respiratory syncytial virus infections - epidemiology - mortality |
4 |
respiratory tract diseases - chemically induced - mortality |
4 |
respiratory tract infections - chemically induced - mortality - virology |
4 |
respiratory tract infections - diagnosis - epidemiology - physiopathology - virology |
4 |
respiratory tract infections - epidemiology |
4 |
reverse transcriptase polymerase chain reaction - methods - statistics & numerical |
4 |
rhinovirus |
4 |
rhinovirus - classification - genetics - isolation & purification |
4 |
rig-i |
4 |
rna, viral - genetics - isolation and purification |
4 |
sciences: comprehensive works |
4 |
seasonal h1n1 |
4 |
sentinel ducks |
4 |
sero-diagnosis |
4 |
severe acute respiratory syndrome - prevention & control - transmission |
4 |
sex |
4 |
shanghai |
4 |
slums |
4 |
spike |
4 |
state–space model |
4 |
statin |
4 |
sterol biosynthesis |
4 |
subtropics |
4 |
swine influenza |
4 |
t-lymphocyte subsets - immunology |
4 |
temperature-sensitivity |
4 |
time-series analysis |
4 |
tissue tropism |
4 |
tlr3 |
4 |
transmissibility |
4 |
tumor necrosis factor-alpha - biosynthesis |
4 |
vaccinia |
4 |
vaccinia virus - genetics - immunology |
4 |
viral structural proteins - metabolism |
4 |
virology - methods - standards |
4 |
virulence - genetics |
4 |
virus interactions |
4 |
wca |
4 |
world health |
4 |
wuhan |
4 |
zometa |
4 |
abattoir |
3 |
acetamides - therapeutic use |
3 |
acute respiratory tract disease |
3 |
adaptor proteins, vesicular transport - metabolism |
3 |
adenoviridae infections - epidemiology - pathology |
3 |
adenoviruses, human - isolation and purification |
3 |
adult croup |
3 |
air travel |
3 |
aircraft |
3 |
airway epithelium cell |
3 |
animal |
3 |
anti-bacterial agents - pharmacology |
3 |
antibodies, monoclonal - administration and dosage - genetics - immunology - therapeutic use |
3 |
antibodies, monoclonal - chemistry - immunology - isolation and purification |
3 |
antibodies, neutralizing - metabolism |
3 |
antibodies, viral - biosynthesis - blood |
3 |
antibodies, viral - chemistry |
3 |
antigenic drift |
3 |
antigenic variation - genetics - immunology |
3 |
antiviral agents - pharmacology - therapeutic use |
3 |
antiviral susceptibility |
3 |
apoptosis - drug effects |
3 |
apoptosis- |
3 |
apoptosis-regulatory-proteins-biosynthesis |
3 |
aquatic bird |
3 |
article |
3 |
asian continental ancestry group |
3 |
astro viruses |
3 |
astrocytes - cytology - immunology - virology |
3 |
astrovirus |
3 |
autophagy |
3 |
autophagy - immunology |
3 |
avastrovirus |
3 |
avian influenza a(h7n9) |
3 |
avian influenza h5n1 |
3 |
b-lymphocytes - immunology - virology |
3 |
bacterial-toxins-biosynthesis |
3 |
biomarker |
3 |
bird diseases - physiopathology - transmission - virology |
3 |
blood donor |
3 |
bmt |
3 |
body weight |
3 |
bronchoscopy |
3 |
carboxy terminal sequence |
3 |
cardiorespiratory |
3 |
cell differentiation |
3 |
cell line, tumor |
3 |
cell survival - drug effects |
3 |
cell-based receptor binding assay |
3 |
cellimmuno |
3 |
cellular distribution |
3 |
chemokine cxcl10 - metabolism |
3 |
chemokines-biosynthesis |
3 |
chick embryo - virology |
3 |
chickenpox |
3 |
children cancer |
3 |
chimera |
3 |
chromatography - methods |
3 |
climate |
3 |
clinical severity |
3 |
close contacts |
3 |
communicable disease control |
3 |
communicable diseases, emerging - mortality - transmission - virology |
3 |
community-acquired infections - epidemiology - microbiology |
3 |
complement 4 |
3 |
contact patterns |
3 |
contract number i-005-436 |
3 |
corticosteroids |
3 |
croup - diagnosis - therapy - virology |
3 |
cxcl10 |
3 |
cyclooxygenase 2 - biosynthesis |
3 |
cyst |
3 |
cysteine proteases - metabolism |
3 |
cytokines - blood - metabolism |
3 |
cytoprotection |
3 |
cytotoxins-biosynthesis |
3 |
dendritic cells - immunology - metabolism - pathology - virology |
3 |
department of health and human services |
3 |
diarrhea-microbiology |
3 |
disease models, animal |
3 |
disease outbreaks - prevention & control - veterinary |
3 |
dna barcoding |
3 |
dna vaccine |
3 |
dogs - microbiology |
3 |
drug administration schedule |
3 |
dsrna |
3 |
emerging or re-emerging diseases |
3 |
emerging pathogens |
3 |
endothelial cell |
3 |
enterovirus |
3 |
epithelial cells - virology |
3 |
epitope mapping |
3 |
epitopes |
3 |
epitopes - immunology |
3 |
erythema - epidemiology - immunology |
3 |
escherichia coli proteins - immunology |
3 |
escherichia-coli-infections-microbiology |
3 |
escherichia-coli-o157-metabolism |
3 |
experiment |
3 |
eyfp, gene encoding the enhanced yellow fluorescent protein |
3 |
fluorescent antibody technique, direct |
3 |
fluorescent antibody technique, direct - methods |
3 |
galactose - analogs & derivatives - biosynthesis |
3 |
general organization for veterinary services |
3 |
generalized cross validation |
3 |
genetic variability |
3 |
ginsenoside |
3 |
ginsenosides - pharmacology |
3 |
haemorrhagic cystitis |
3 |
health hazard |
3 |
health policy |
3 |
heart failure - epidemiology |
3 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - metabolism |
3 |
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
3 |
hemagglutinins - chemistry |
3 |
hepatitis b - epidemiology - prevention & control |
3 |
hepatitis b antibodies - blood |
3 |
hepatitis b surface antigens - immunology |
3 |
hepatitis b vaccine |
3 |
hepatitis b vaccines - administration & dosage - immunology |
3 |
hfmd |
3 |
hhv 6 |
3 |
hong kong influenza |
3 |
hospitalisation |
3 |
hospitalization - economics |
3 |
hospitalization disease burden |
3 |
host-pathogen interactions |
3 |
human cell |
3 |
human respiratory viruses |
3 |
human umbilical vein endothelial cells - drug effects - immunology - pathology - virology |
3 |
humdisease |
3 |
humidity |
3 |
hydrogen-ion concentration |
3 |
ifn |
3 |
immunity, innate - physiology |
3 |
immunization, secondary |
3 |
immunoglobulin m - immunology |
3 |
immunologic factors - pharmacology |
3 |
immunologic memory - immunology |
3 |
immunoprecipitation |
3 |
immunosuppressive agents - therapeutic use |
3 |
in situ nick-end labeling |
3 |
inflammation |
3 |
inflammation mediators - metabolism |
3 |
influenza a (h1n1) |
3 |
influenza a (h3n2) |
3 |
influenza a virus - classification - genetics - immunology - isolation and purification |
3 |
influenza a virus - genetics - metabolism |
3 |
influenza a virus, h1n1 subtype - genetics - isolation and purification - pathogenicity |
3 |
influenza a virus, h3n2 subtype - metabolism |
3 |
influenza a virus, h3n2 subtype - pathogenicity |
3 |
influenza a virus, h5n1 subtype - classification - genetics - immunology - isolation & purification |
3 |
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity - physiology |
3 |
influenza a virus, h5n1 subtype - genetics - pathogenicity - physiology |
3 |
influenza a virus, h5n1 subtype - isolation & purification |
3 |
influenza a virus, h5n1 subtype - isolation and purification - pathogenicity |
3 |
influenza a virus, h9n2 subtype - growth and development - physiology |
3 |
influenza a virus, h9n2 subtype - immunology |
3 |
influenza a virus, h9n2 subtype - pathogenicity |
3 |
influenza in birds - epidemiology - prevention & control - transmission - virology |
3 |
influenza in birds - immunology |
3 |
influenza in birds - immunology - prevention and control |
3 |
influenza in birds - immunology - prevention and control - virology |
3 |
influenza vaccines - administration & dosage - adverse effects - immunology |
3 |
influenza vaccines - economics |
3 |
influenza vaccines - immunology - supply & distribution |
3 |
influenza vaccines - therapeutic use |
3 |
influenza virus a h1n1 |
3 |
influenza, human |
3 |
influenza, human - blood - immunology - virology |
3 |
influenza, human - blood - mortality - virology |
3 |
influenza, human - complications - diagnosis - epidemiology - therapy |
3 |
influenza, human - diagnosis - epidemiology - transmission - virology |
3 |
influenza, human - drug therapy - epidemiology - prevention & control - transmission |
3 |
influenza, human - economics - epidemiology |
3 |
influenza, human - epidemiology - immunology - physiopathology |
3 |
influenza, human - epidemiology - therapy |
3 |
influenza, human - immunology - mortality - pathology |
3 |
influenza, human - immunology - prevention and control |
3 |
influenza, human - metabolism - virology |
3 |
influenza, human - mortality - pathology - virology |
3 |
influenza-a-virus,-h1n1-subtype-immunology |
3 |
influenza-a-virus,-h5n1-subtype-immunology |
3 |
influenza-a-virus,-h5n1-subtype-pathogenicity |
3 |
influenza-a-virus,-h9n2-subtype-immunology |
3 |
injections, intramuscular |
3 |
interferon |
3 |
interferon regulatory factor |
3 |
interferon-alpha - biosynthesis |
3 |
interleukin-6 - biosynthesis - genetics |
3 |
interleukin-6 - metabolism |
3 |
intermethod comparison |
3 |
ip-11 |
3 |
jeddah |
3 |
kidney failure, chronic - etiology - surgery |
3 |
kidney transplantation - immunology |
3 |
laboratory diagnosis |
3 |
ligand sequestration |
3 |
lineage differentiation |
3 |
live poultry markets |
3 |
livestock - virology |
3 |
lung alveolus epithelium |
3 |
macrophages-immunology |
3 |
macrophages-virology |
3 |
mammal cell |
3 |
mdck, madin-darby canine kidney |
3 |
meca |
3 |
membrane glycoproteins - genetics - immunology - physiology |
3 |
membrane glycoproteins - immunology |
3 |
membrane-glycoproteins-biosynthesis |
3 |
mers‐cov |
3 |
methicillin-resistant s. aureus |
3 |
methicillin-resistant staphylococcus aureus - drug effects - isolation & purification |
3 |
mice, inbred c57bl |
3 |
micrornas - metabolism |
3 |
mir-15b |
3 |
models, molecular |
3 |
monocytes |
3 |
myeloid differentiation primary response gene 88 |
3 |
nadph oxidase - metabolism |
3 |
nasopharyngeal aspirates (npa) |
3 |
nasopharyngeal flocked swabs (npfs) |
3 |
neuraminidase |
3 |
neuraminidase - antagonists & inhibitors - genetics |
3 |
neurodegenerative disease |
3 |
neurons - cytology - immunology - virology |
3 |
novel |
3 |
ns1, gene encoding the non-structural protein ns1 |
3 |
nuclear magnetic resonance |
3 |
nucleotide-sensing receptor |
3 |
orthomyxoviridae |
3 |
orthomyxoviridae - drug effects - immunology - pathogenicity |
3 |
orthomyxoviridae - genetics - isolation and purification - pathogenicity |
3 |
orthomyxoviridae - pathogenicity |
3 |
orthomyxoviridae infections - metabolism |
3 |
orthomyxoviridae infections - pathology - transmission - veterinary |
3 |
oxidative stress |
3 |
pain - epidemiology - immunology |
3 |
pandemic h1n1 2009 |
3 |
pandemic influenza |
3 |
pandemics - prevention and control |
3 |
parainfluenza virus 1, human - isolation & purification |
3 |
parainfluenza virus 2, human - isolation & purification |
3 |
parainfluenza virus type 3 |
3 |
paramyxoviridae infections - epidemiology - pathology |
3 |
pdz domain |
3 |
pediatric |
3 |
phospholipids - metabolism |
3 |
pneumonia - epidemiology |
3 |
pneumonia, viral - radiography - virology |
3 |
population-based |
3 |
priority journal |
3 |
protein motif |
3 |
protein protein interaction |
3 |
pseudotyped lentiviral particles |
3 |
ptgs, post-transcriptional gene silencing |
3 |
pulmonary alveoli - virology |
3 |
pulmonary disease, chronic obstructive - epidemiology |
3 |
rabbits |
3 |
rapid antigen detection kit |
3 |
real time quantitative rt-pcr |
3 |
real-time polymerase chain reaction |
3 |
reassortant virus |
3 |
reassortant viruses - genetics - isolation and purification - pathogenicity |
3 |
reassortment |
3 |
receptor interaction |
3 |
receptors, ccr1 - genetics - immunology - metabolism |
3 |
receptors, ccr3 - genetics - immunology - metabolism |
3 |
receptors, ccr5 - genetics - immunology - metabolism |
3 |
receptors, cell surface - chemistry - genetics - metabolism |
3 |
receptors, immunologic - genetics - metabolism |
3 |
receptors, virus - biosynthesis |
3 |
receptors, virus - chemistry - genetics - metabolism |
3 |
receptors, virus - chemistry - metabolism |
3 |
recombinant proteins - genetics - metabolism |
3 |
reduced dosage |
3 |
respiration, artificial |
3 |
respiratory diseases |
3 |
respiratory distress syndrome, adult - metabolism |
3 |
respiratory mucosa - cytology - metabolism |
3 |
respiratory syncytial virus infections - epidemiology - pathology |
3 |
respiratory tract infection |
3 |
respiratory tract infections - diagnosis - drug therapy - economics |
3 |
respiratory tract infections - virology |
3 |
respiratory virus |
3 |
respiratory viruses |
3 |
rna, messenger - biosynthesis |
3 |
rnai, rna interference |
3 |
rt-ddpcr |
3 |
rt-pcr |
3 |
sapogenins - pharmacology |
3 |
sars virus - immunology - pathogenicity |
3 |
sars virus - immunology - physiology |
3 |
saturation transfer difference |
3 |
sccmec |
3 |
seasonal h1n1 and h3n2 |
3 |
serologic tests - standards |
3 |
serotypes |
3 |
serum amyloid a |
3 |
severe acute respiratory syndrome - blood - diagnosis |
3 |
severe acute respiratory syndrome - blood - diagnosis - immunology |
3 |
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control |
3 |
severe acute respiratory syndrome - immunology |
3 |
severe acute respiratory syndrome - metabolism |
3 |
sialoglycoproteins - chemistry - metabolism |
3 |
sirna, small-interfering rna |
3 |
socioeconomic burden |
3 |
south-east asia |
3 |
spike glycoprotein |
3 |
spike protein |
3 |
sri lanka |
3 |
standardization |
3 |
staphylococcal infections - epidemiology - microbiology |
3 |
staphylococcus intermedius |
3 |
swine diseases - pathology - virology |
3 |
t-lymphocytes - metabolism |
3 |
temperature |
3 |
tight junction |
3 |
tissue culture techniques |
3 |
tlr10 |
3 |
toll-like receptor |
3 |
toll-like receptor 4 - metabolism |
3 |
tomography, x-ray computed |
3 |
trachea - virology |
3 |
transmission chain |
3 |
transplant |
3 |
tropics |
3 |
vaccination - adverse effects |
3 |
varicella |
3 |
victoria |
3 |
viral envelope proteins - immunology |
3 |
viral genomic load |
3 |
viral infection |
3 |
virus diseases - diagnosis - drug therapy - economics |
3 |
virus diseases - virology |
3 |
virus morphogenesis |
3 |
virus neutralization |
3 |
viruses - genetics - isolation & purification |
3 |
wiskott-aldrich syndrome |
3 |
yamagata |
3 |
zoonotic infections |
3 |
α1-antitrypsin |
3 |
2.3.4.4 |
2 |
2009 h1n1 influenzaanti |
2 |
8b protein |
2 |
a/h7n9 |
2 |
a/h9n2 |
2 |
abattoir worker |
2 |
accessory proteins |
2 |
accidental deaths |
2 |
acute respiratory distress syndrome |
2 |
adaptation, physiological |
2 |
adaptation, physiological - genetics |
2 |
adaptive immunity; infectious disease; molecular biology; molecular diagnosis; virology. |
2 |
ade |
2 |
alveolar macrophage |
2 |
amantadine |
2 |
anemia, hypochromic - etiology |
2 |
angular cheilitis |
2 |
antibodies, bacterial - biosynthesis - genetics - immunology |
2 |
antibodies, monoclonal - chemistry - immunology |
2 |
antibodies, monoclonal - immunology - isolation and purification |
2 |
antibodies, neutralizing - chemistry - immunology |
2 |
antibodies, neutralizing - immunology - isolation and purification |
2 |
antibodies, protozoan - genetics - immunology |
2 |
antibodies, viral - analysis |
2 |
antibodies, viral - immunology - isolation and purification |
2 |
antibody production |
2 |
antigenicity |
2 |
antigens, bacterial - genetics - immunology - isolation & purification |
2 |
antigens, protozoan - genetics - immunology |
2 |
antigens, surface - immunology |
2 |
antigens, viral - chemistry - genetics - immunology |
2 |
antigens, viral - genetics - immunology |
2 |
aquatic poultry |
2 |
arterial oxygen tension |
2 |
artificial ventilation |
2 |
asthma |
2 |
b cell clonal expansion |
2 |
b cell repertoires |
2 |
backyards |
2 |
bat coronaviruses |
2 |
bcr selection |
2 |
bcr sharing |
2 |
betacorona |
2 |
biomedical research |
2 |
biosensing techniques - instrumentation - methods |
2 |
bird diseases - transmission - virology |
2 |
blood donors |
2 |
blood sampling |
2 |
blood-borne pathogens |
2 |
body response |
2 |
breast cancer |
2 |
candida albicans - isolation & purification |
2 |
candida species |
2 |
canine influenza virus |
2 |
capsid proteins |
2 |
carbohydrates |
2 |
carboxypeptidases - metabolism |
2 |
cattle - microbiology |
2 |
cattle diseases - microbiology |
2 |
cell culture techniques |
2 |
centers for disease control and prevention (u.s.) |
2 |
central nervous system infection |
2 |
central nervous system viral diseases - pathology - physiopathology - virology |
2 |
cheilitis - complications - microbiology - pathology |
2 |
chemokine ccl5 - genetics |
2 |
chemokines - genetics |
2 |
chick embryo |
2 |
chinese |
2 |
clinical article |
2 |
clinical diagnosis |
2 |
clinical outcome |
2 |
cloning, molecular |
2 |
closure |
2 |
codon |
2 |
communicable diseases |
2 |
companion and shelter dogs |
2 |
computer assisted tomography |
2 |
contact dynamics |
2 |
convalescent sera |
2 |
coronavirinae |
2 |
coronavirus - genetics |
2 |
covid-19 vaccines |
2 |
cross infection - prevention & control |
2 |
cross infection - prevention & control - transmission |
2 |
cross-reactivity |
2 |
cross-species transmission |
2 |
culicidae - parasitology |
2 |
cyclooxygenase 2 - genetics - metabolism |
2 |
cyclooxygenase inhibitors - pharmacology - therapeutic use |
2 |
cytokines - genetics |
2 |
cytomegalovirus (cmv) |
2 |
cytomegalovirus - genetics - immunology |
2 |
diabetes mellitus |
2 |
diagnosis |
2 |
disease control |
2 |
disease outbreaks - veterinary |
2 |
disease severity |
2 |
disease vectors |
2 |
dnaemia |
2 |
down-regulation |
2 |
drowning |
2 |
duck |
2 |
eastern region |
2 |
ebolavirus - physiology |
2 |
efficacy |
2 |
egypt |
2 |
emerging infections |
2 |
emerging infectious diseases |
2 |
encephalitis |
2 |
encephalitis virus, japanese - immunology |
2 |
encephalopathy |
2 |
envelope (e) |
2 |
enzyme-linked immunosorbent assay - methods - statistics & numerical data |
2 |
epstein-barr virus infections - diagnosis - immunology |
2 |
escherichia coli - metabolism - pathogenicity |
2 |
escherichia coli infections - microbiology - veterinary |
2 |
escherichia coli o157 - isolation & purification - metabolism |
2 |
european union |
2 |
exanthema-subitum-diagnosis |
2 |
familial farm |
2 |
flying fox |
2 |
geese |
2 |
geese - virology |
2 |
genetic-predisposition-to-disease |
2 |
h5 influenza virus |
2 |
h5n1 virus |
2 |
h5n8 |
2 |
hemagglutinin glycoproteins, influenza virus - biosynthesis - genetics - metabolism |
2 |
hemagglutinin glycoproteins, influenza virus - chemistry |
2 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - immunology |
2 |
hemagglutinin glycoproteins, influenza virus - immunology |
2 |
hemorrhagic fever, ebola - diagnosis - prevention & control - therapy - transmission |
2 |
herpesviridae infections - blood - immunology - virology |
2 |
herpesvirus 4, human - genetics - immunology |
2 |
herpesvirus 6, human - genetics - immunology |
2 |
herpesvirus 6, human - isolation & purification |
2 |
herpesvirus 7, human - genetics - immunology |
2 |
high-pathogenicity avian influenza |
2 |
histological techniques |
2 |
histology |
2 |
host |
2 |
human coronaviruses |
2 |
human herpesvirus 6 (hhv6) and 7 (hhv7) |
2 |
human influenza h7n9 |
2 |
human influenza virus |
2 |
hydrocephalus |
2 |
immunoassay - veterinary |
2 |
immunodominant epitopes - chemistry - immunology |
2 |
immunoenzyme techniques - veterinary |
2 |
indonesia |
2 |
infection control - methods |
2 |
infection control, dental - methods |
2 |
infectious disease |
2 |
infectious disease transmission, patient-to-professional - prevention & control |
2 |
influenza a virus - chemistry - classification |
2 |
influenza a virus - chemistry - classification - genetics - pathogenicity |
2 |
influenza a virus - classification - enzymology - genetics - immunology |
2 |
influenza a virus - classification - genetics - immunology - pathogenicity |
2 |
influenza a virus - classification - immunology |
2 |
influenza a virus - genetics - physiology |
2 |
influenza a virus - isolation & purification - pathogenicity - physiology |
2 |
influenza a virus - pathogenicity - physiology |
2 |
influenza a virus, h1n1 subtype - genetics - physiology - ultrastructure |
2 |
influenza a virus, h5n1 subtype - chemistry |
2 |
influenza a virus, h5n1 subtype - classification - drug effects - genetics |
2 |
influenza a virus, h5n1 subtype - classification - genetics - immunology |
2 |
influenza a virus, h5n1 subtype - drug effects - physiology |
2 |
influenza a virus, h5n1 subtype - genetics - physiology - ultrastructure |
2 |
influenza a virus, h5n1 subtype - growth & development - immunology - pathogenicity |
2 |
influenza b virus - immunology |
2 |
influenza in birds - blood - diagnosis - virology |
2 |
influenza in birds - drug therapy |
2 |
influenza in birds - epidemiology - immunology - transmission |
2 |
influenza pandemic h1n1 |
2 |
influenza vaccines - chemistry |
2 |
influenza, human - blood - diagnosis - virology |
2 |
influenza, human - diagnosis - etiology - physiopathology |
2 |
influenza, human - diagnosis - immunology - virology |
2 |
influenza, human - drug therapy |
2 |
influenza, human - drug therapy - epidemiology - virology |
2 |
influenza, human - epidemiology - transmission |
2 |
influenza, human - epidemiology - veterinary - virology |
2 |
information center |
2 |
insect vectors |
2 |
interferon regulatory factor-3 - genetics - metabolism |
2 |
interferon-gamma - genetics |
2 |
interferon-type-ii-genetics |
2 |
intestines - virology |
2 |
intra-host |
2 |
kidney - cytology |
2 |
kidney transplantation - adverse effects |
2 |
lateral flow assay |
2 |
lentivirus - genetics - pathogenicity - physiology |
2 |
lentivirus - metabolism |
2 |
leukocytes, mononuclear - immunology - virology |
2 |
leukoplakia, oral - etiology |
2 |
lineages |
2 |
live poultry market |
2 |
luciferases - genetics |
2 |
macrophages - cytology - drug effects - virology |
2 |
macrophages - physiology - virology |
2 |
madin darby canine kidney cells |
2 |
magnetic resonance spectroscopy - methods - standards |
2 |
malaria - immunology |
2 |
maternal antibody |
2 |
messenger |
2 |
microbiology |
2 |
molecular detection |
2 |
molecular weight |
2 |
monocyte |
2 |
mouth diseases - virology |
2 |
multivariate analysis |
2 |
mutational spectra |
2 |
n-acetylneuraminic acid - metabolism |
2 |
network analysis |
2 |
neuraminidase - antagonists & inhibitors |
2 |
neuraminidase - chemistry - metabolism |
2 |
neuraminidase - genetics - immunology |
2 |
neuraminidase - genetics - physiology |
2 |
neuraminidase inhibitor |
2 |
neurodegenerative diseases |
2 |
neurological complications |
2 |
newcastle disease virus |
2 |
nitrobenzenes - pharmacology - therapeutic use |
2 |
nmr spectroscopy |
2 |
novel coronaviruses |
2 |
ns-398 |
2 |
nuclear magnetic resonance, biomolecular |
2 |
oligonucleotide array sequence analysis |
2 |
oral hygiene |
2 |
orthomyxoviridae - chemistry - enzymology |
2 |
orthomyxoviridae infections - diagnosis - immunology - virology |
2 |
orthomyxoviridae infections - immunology |
2 |
orthomyxoviridae infections - prevention & control |
2 |
orthomyxovirus |
2 |
oseltamivir - pharmacology |
2 |
outbreak |
2 |
ovum - immunology |
2 |
pao2/ fio2 |
2 |
particle size |
2 |
peramivir |
2 |
peripheral blood leukocytes |
2 |
phylogenetics |
2 |
picobirnavirus - classification - genetics - isolation and purification - pathogenicity |
2 |
pigeons |
2 |
pigs |
2 |
plasmodium vivax - immunology - pathogenicity |
2 |
polymerase chain reaction (pcr) |
2 |
polymerase fidelity |
2 |
polymorphism,-single-nucleotide |
2 |
poultry diseases - virology |
2 |
primary infection |
2 |
protease inhibitors |
2 |
proteasome pathway |
2 |
protective clothing |
2 |
pulmonary alveoli - cytology |
2 |
pulmonary alveoli - metabolism |
2 |
quail |
2 |
questionnaires |
2 |
rapid antigen test |
2 |
reactivation |
2 |
reassortant viruses - immunology |
2 |
reassortant viruses - pathogenicity |
2 |
receptors, cell surface - chemistry |
2 |
receptors, virus - metabolism |
2 |
recombinant fowl pox |
2 |
renal allograft |
2 |
respiratory distress syndrome, adult - enzymology - etiology |
2 |
respiratory system |
2 |
respiratory tract infections - epidemiology - transmission - veterinary - virology |
2 |
ressortment |
2 |
rest day |
2 |
reverse genetics |
2 |
reverse transcriptase polymerase chain reaction - veterinary |
2 |
rna |
2 |
rna virus infections - epidemiology - transmission - veterinary - virology |
2 |
roc curve |
2 |
rsv |
2 |
sars virus - genetics - isolation and purification |
2 |
sars virus - genetics - metabolism - physiology |
2 |
sars virus - isolation & purification - pathogenicity |
2 |
selective cox-2 inhibitor |
2 |
serodiagnostic |
2 |
seroepidemiological study |
2 |
serological responses |
2 |
severe acute respiratory syndrome - complications - enzymology |
2 |
severe acute respiratory syndrome - diagnosis - epidemiology - transmission - virology |
2 |
severe acute respiratory syndrome - diagnosis - etiology - physiopathology |
2 |
severe acute respiratory syndrome - drug therapy |
2 |
severe acute respiratory syndrome - etiology - immunology |
2 |
severe acute respiratory syndrome - genetics |
2 |
severe acute respiratory syndrome - pathology - virology |
2 |
severe acute respiratory syndrome coronavirus (sars-cov) |
2 |
severe-acute-respiratory-syndrome-genetics |
2 |
shiga toxin 1 - genetics - immunology - isolation & purification |
2 |
shiga toxin 2 - chemistry - genetics - metabolism - toxicity |
2 |
shiga toxin 2 - genetics - immunology - isolation & purification |
2 |
shiga toxins - genetics - isolation & purification |
2 |
sialic acid |
2 |
sialic acids |
2 |
signal transduction - drug effects |
2 |
skin disease |
2 |
sri lanka - epidemiology |
2 |
sri lankans |
2 |
staphylococcus aureus - isolation & purification |
2 |
sulfonamides - pharmacology - therapeutic use |
2 |
survival analysis |
2 |
sus scrofa - virology |
2 |
swimming pools |
2 |
swine - microbiology |
2 |
swine diseases - diagnosis - immunology - virology |
2 |
swine movements |
2 |
t cell response |
2 |
transcriptomic |
2 |
transplantation, homologous |
2 |
travel |
2 |
tunisia |
2 |
ubiquitin-independent |
2 |
united states |
2 |
vaccines, synthetic - immunology |
2 |
value chain |
2 |
variation |
2 |
viral envelope proteins - metabolism |
2 |
viral proteins - genetics - physiology |
2 |
viral proteins - metabolism |
2 |
viral-load |
2 |
virion - genetics - pathogenicity - physiology |
2 |
virus assembly - genetics - physiology |
2 |
virus replication - drug effects |
2 |
virus replication - genetics |
2 |
virus replication - physiology |
2 |
waterfowl |
2 |
world health organization |
2 |
zanamivir |
2 |
(pig) |
1 |
acute hepatitis |
1 |
acyclovir - analogs & derivatives - therapeutic use |
1 |
acyclovir/analogs and derivatives |
1 |
aedes |
1 |
alphavirus - growth & development - immunology |
1 |
alphavirus - isolation & purification |
1 |
altitude |
1 |
ambulatory care |
1 |
ambulatory care - economics |
1 |
animal-human interface |
1 |
animals, domestic - immunology |
1 |
animals, suckling |
1 |
anopheles - parasitology |
1 |
antibodies, neutralizing - immunology |
1 |
antibodies, protozoan - analysis - immunology |
1 |
antibodies, protozoan - immunology |
1 |
antibodies, viral |
1 |
antibody affinity |
1 |
antibody diagnostic |
1 |
antibody formation |
1 |
antigen-antibody complex |
1 |
antigen-antibody reactions |
1 |
antigens, protozoan - analysis |
1 |
antigens, protozoan - immunology |
1 |
antigens, viral |
1 |
antiviral therapy |
1 |
apicomplexa - immunology |
1 |
arbovirus infections - epidemiology - immunology - veterinary |
1 |
arboviruses - genetics - immunology |
1 |
arboviruses - immunology |
1 |
asymptomatic primary ebv infection |
1 |
backyard |
1 |
bacterial infections - diagnosis - therapy |
1 |
bacterial infections - epidemiology |
1 |
bacterial toxins - biosynthesis - genetics |
1 |
bacterial toxins - biosynthesis - immunology |
1 |
bacterial vaccines - immunology |
1 |
binding, competitive |
1 |
biological assay |
1 |
biotin - analysis |
1 |
bird diseases - epidemiology - mortality - virology |
1 |
birds - immunology - virology |
1 |
bone marrow transplant |
1 |
bronchiolitis |
1 |
bronchiolitis - immunology - prevention & control |
1 |
bunyaviridae - immunology |
1 |
calf |
1 |
cambodia |
1 |
cambodia - epidemiology |
1 |
cat diseases - epidemiology - virology |
1 |
cattle diseases - epidemiology - microbiology |
1 |
cd8-positive t-lymphocytes - immunology |
1 |
cell nucleus - chemistry |
1 |
chickenpox - epidemiology - ethnology |
1 |
clinical |
1 |
clone cells - immunology |
1 |
complement activation |
1 |
crosses, genetic |
1 |
culex - microbiology |
1 |
culicidae |
1 |
culicidae - microbiology |
1 |
cytomegalovirus |
1 |
cytomegalovirus - genetics - immunology - isolation & purification |
1 |
cytomegalovirus - isolation & purification |
1 |
cytomegalovirus - isolation & purification - physiology |
1 |
cytomegalovirus infections - blood - etiology - immunology |
1 |
cytomegalovirus infections - complications - diagnosis |
1 |
cytomegalovirus infections - complications - immunology - virology |
1 |
cytomegalovirus infections - diagnosis |
1 |
cytoplasm - chemistry |
1 |
cytotoxins - biosynthesis - immunology |
1 |
deaff test |
1 |
dengue - epidemiology - immunology - veterinary |
1 |
dengue virus - immunology |
1 |
deoxyribonucleases, type ii site-specific - genetics |
1 |
developing countries |
1 |
diarrhea - epidemiology - veterinary |
1 |
diarrhea - microbiology - parasitology |
1 |
diarrhea, infantile - microbiology - parasitology |
1 |
diarrhoea |
1 |
disease transmission, infectious |
1 |
dna - genetics |
1 |
dna probes |
1 |
dna restriction enzymes |
1 |
dna, viral - analysis |
1 |
drug therapy - adverse effects |
1 |
edema disease |
1 |
electrophoresis, polyacrylamide gel |
1 |
emerging |
1 |
encephalitis virus, california - immunology |
1 |
encephalitis virus, japanese - isolation & purification |
1 |
encephalitis viruses, tick-borne - genetics - isolation & purification |
1 |
encephalitis, california - epidemiology |
1 |
encephalitis, herpes simplex - diagnosis - drug therapy |
1 |
encephalitis, herpes simplex/drug therapy |
1 |
encephalitis, japanese - epidemiology - immunology |
1 |
encephalitis, japanese - epidemiology - veterinary |
1 |
encephalitis, tick-borne - epidemiology |
1 |
endemic diseases |
1 |
enterotoxins - biosynthesis - genetics |
1 |
enterotoxins - biosynthesis - immunology |
1 |
enzyme-linked immunosorbent assay - veterinary |
1 |
epidemiological surveillance |
1 |
epidemiology, molecular |
1 |
epidermal necrolysis |
1 |
epidermal necrolysis, toxic - etiology |
1 |
epitopes - genetics - immunology |
1 |
epstein-barr virus infections - diagnosis - virology |
1 |
eqa |
1 |
erythrocytes - parasitology |
1 |
erythrocytes - parasitology - ultrastructure |
1 |
escherichia coli |
1 |
escherichia coli - genetics - immunology - metabolism |
1 |
escherichia coli - genetics - isolation & purification |
1 |
escherichia coli infections - epidemiology - veterinary |
1 |
escherichia coli proteins |
1 |
evaluation tests |
1 |
experimental |
1 |
external quality assurance |
1 |
feces - microbiology |
1 |
feces - microbiology - parasitology |
1 |
fever - microbiology |
1 |
fever - microbiology - therapy |
1 |
finland - epidemiology |
1 |
flavivirus |
1 |
flavivirus - growth & development - immunology |
1 |
flavivirus - immunology |
1 |
fluorescent antibody technique |
1 |
fluorescent antibody technique, indirect |
1 |
food microbiology |
1 |
frozen sections |
1 |
gene order |
1 |
genes, bacterial |
1 |
genetic changes |
1 |
goats |
1 |
goats - parasitology |
1 |
graft vs host disease - etiology |
1 |
graft vs host disease - virology |
1 |
gvhd |
1 |
h5n6 |
1 |
h7n7 |
1 |
hemagglutination inhibition tests - veterinary |
1 |
hemagglutinins - genetics |
1 |
hematologic diseases - therapy |
1 |
herpes virus |
1 |
herpes zoster - epidemiology - ethnology |
1 |
herpesviridae - immunology |
1 |
herpesviridae infections - complications - immunology - virology |
1 |
herpesvirus 3, human - classification - genetics |
1 |
herpesvirus 4, human - genetics - isolation & purification |
1 |
herpesvirus 6, human - genetics - immunology - isolation & purification |
1 |
herpesvirus 7, human - genetics - immunology - isolation & purification |
1 |
hev |
1 |
highly pathogenic avian influenza virus |
1 |
hong kong infancy |
1 |
human ctl |
1 |
human herpesvirus 6 |
1 |
human neutralizing antibody against m |
1 |
hybridomas |
1 |
il-6 |
1 |
ileal diseases - etiology - immunology - microbiology |
1 |
immune sera - immunology |
1 |
immunocompromised |
1 |
immunofluorescence |
1 |
immunoglobulin a - blood - immunology |
1 |
immunoglobulin fab fragments |
1 |
immunoglobulin g |
1 |
immunoglobulin g - blood - immunology |
1 |
immunoglobulin m - analysis |
1 |
immunoglobulin m - blood - immunology |
1 |
immunologic factors - therapeutic use |
1 |
influenza a virus - classification - genetics - isolation & purification - pathogenicity |
1 |
influenza a virus - classification - immunology - isolation & purification |
1 |
influenza a virus, h1n1 subtype - genetics - immunology - physiology |
1 |
influenza a virus, h5n1 subtype - genetics - immunology - physiology |
1 |
influenza a virus, h5n1 subtype - immunology - isolation and purification |
1 |
influenza a virus, h7n7 subtype - pathogenicity - physiology |
1 |
influenza a virus, h9n2 subtype - pathogenicity - physiology |
1 |
influenza in birds |
1 |
influenza in birds - epidemiology |
1 |
influenza pseudotyped lentiviral particles |
1 |
influenza type a |
1 |
influenza, human - blood - immunology |
1 |
influenza, human - classification - diagnosis |
1 |
influenza, human - complications - immunology - virology |
1 |
influenza, human - diagnosis - epidemiology - therapy - virology |
1 |
influenza, human - diagnosis - immunology |
1 |
influenza, human - epidemiology - genetics |
1 |
influenza, human - epidemiology - prevention & control |
1 |
insect vectors - microbiology |
1 |
insect vectors - parasitology |
1 |
interferon type ii - analysis |
1 |
interleukin-6 - blood |
1 |
intestinal diseases, parasitic - epidemiology |
1 |
intestinal perforation - etiology - immunology - microbiology |
1 |
ixodes - virology |
1 |
kidney transplantation - adverse effects - immunology |
1 |
kingdom of saudi arabia |
1 |
lentivirus - genetics |
1 |
longitudinal study |
1 |
lung - immunology |
1 |
lung injury - drug therapy - etiology - immunology |
1 |
macaca |
1 |
macaca fascicularis - immunology - virology |
1 |
macrophages - immunology - microbiology |
1 |
macrophages - microbiology |
1 |
malaria - blood |
1 |
malaria - epidemiology - immunology |
1 |
malaria - epidemiology - parasitology |
1 |
malaria - immunology - transmission |
1 |
malaria - parasitology |
1 |
malaria - parasitology - transmission |
1 |
malaria vaccines - immunology |
1 |
malaria, vivax - prevention & control - transmission |
1 |
mannose-binding lectin - blood - genetics |
1 |
marrow graft |
1 |
maximum-likelihood |
1 |
mengovirus - immunology |
1 |
microbial ecology |
1 |
microscopy, electron - methods |
1 |
monkey diseases - epidemiology - immunology - transmission |
1 |
multicenter studies as topic |
1 |
nairovirus - isolation & purification |
1 |
neighbour-joining |
1 |
nucleic acid hybridization |
1 |
occupational exposure |
1 |
orbivirus - isolation & purification |
1 |
orthobunyavirus - isolation & purification |
1 |
orthomyxoviridae - genetics - pathogenicity |
1 |
orthomyxoviridae - immunology |
1 |
orthomyxoviridae infections - immunology - veterinary |
1 |
palivizumab prophylaxis |
1 |
paraffin embedding - methods |
1 |
peptides - immunology |
1 |
plasmodium falciparum - immunology |
1 |
plasmodium falciparum - isolation & purification |
1 |
plasmodium vivax - genetics - immunology |
1 |
plasmodium vivax - immunology |
1 |
plasmodium vivax - isolation & purification |
1 |
pneumonia - diagnosis - immunology - mortality - physiopathology |
1 |
population density |
1 |
precipitin tests |
1 |
predictive value of tests |
1 |
protein binding |
1 |
proteins - immunology |
1 |
protozoan proteins |
1 |
protozoan proteins - genetics - immunology |
1 |
protozoan vaccines - immunology |
1 |
pseudoparticle |
1 |
pseudoparticle virus neutralization assays |
1 |
public policy |
1 |
radioimmunoassay |
1 |
rain |
1 |
renal transplant |
1 |
renal transplantation |
1 |
respiratory syncytial viruses |
1 |
rodentia |
1 |
rotavirus infections - epidemiology |
1 |
rural population |
1 |
s-gene |
1 |
salivary glands - chemistry - microbiology |
1 |
salivary glands - parasitology |
1 |
salmonella typhi - immunology |
1 |
sars dna vaccine |
1 |
sars virus - classification - genetics - isolation & purification - pathogenicity |
1 |
sars virus - immunology - isolation & purification - pathogenicity - physiology |
1 |
sars virus - pathogenicity - physiology |
1 |
scid-pbl/hu |
1 |
scientific community |
1 |
sequence alignment |
1 |
sequence analysis - methods |
1 |
sequence deletion - genetics |
1 |
severe acute respiratory syndrome - complications - immunology - pathology - virology |
1 |
severe acute respiratory syndrome - epidemiology - physiopathology - virology |
1 |
severe combined immunodeficiency |
1 |
severe combined immunodeficiency - therapy - virology |
1 |
shell vial culture |
1 |
shiga toxin 1 |
1 |
shiga-like toxin |
1 |
single nucleotide variation |
1 |
skin - virology |
1 |
stevens-johnson syndrome |
1 |
stevens-johnson syndrome - chemically induced |
1 |
streptococcus pneumoniae - immunology - pathogenicity |
1 |
superinfection - epidemiology |
1 |
swine diseases - epidemiology |
1 |
target organ |
1 |
ticks - virology |
1 |
tnf-α |
1 |
togaviridae - immunology |
1 |
toxic aetiology |
1 |
transmissible diseases |
1 |
transplantation, autologous |
1 |
typhoid fever - complications - immunology |
1 |
valine - analogs & derivatives - therapeutic use |
1 |
verocytotoxin |
1 |
verotoxin |
1 |
viral co-factor |
1 |
viral envelope proteins |
1 |
viral infections |
1 |
viral proteins - immunology |
1 |
viremia - complications |
1 |
virion - genetics |
1 |
virus diagnosis |
1 |
virus diseases - diagnosis |
1 |
virus dissemination |
1 |
virus infections |
1 |
west nile virus - growth & development - immunology |
1 |
zoonoses - epidemiology - virology |
1 |
zoonotic influenza |
1 |